The Epitope-substituted DNA Vaccine Improves Safety and Immunogenicity against Dengue Virus Type 2
博士 === 國防醫學院 === 生命科學研究所 === 103 === Dengue virus (DENV), a global and mosquito-borne disease, is divided into four serotypes (DENV1-4). Cross-reactive and non-neutralizing antibodies against envelope (E) protein of DENV bind to the Fcγ receptors (FcγR) of cells, and thereby exacerbate viral infecti...
Main Authors: | Chung-Tao Tang, 唐中道 |
---|---|
Other Authors: | Han-Chung Wu |
Format: | Others |
Language: | en_US |
Published: |
2015
|
Online Access: | http://ndltd.ncl.edu.tw/handle/j58wkh |
Similar Items
-
An Epitope-Substituted DNA Vaccine Improves Safety and Immunogenicity against Dengue Virus Type 2.
by: Chung-Tao Tang, et al.
Published: (2015-01-01) -
Study on the immunogenicity of different genotype DNA vaccines of Dengue virus serotype 2
by: Jedhan Ucat Galula, et al.
Published: (2016) -
In silico Designed Ebola Virus T-Cell Multi-Epitope DNA Vaccine Constructions Are Immunogenic in Mice
by: Sergei I. Bazhan, et al.
Published: (2019-03-01) -
Immunoinformatics design of a novel epitope-based vaccine candidate against dengue virus
by: Adewale Oluwaseun Fadaka, et al.
Published: (2021-10-01) -
Generation of Monoclonal Antibodies against Dengue Virus Type 4 and Identification of Enhancing Epitopes on Envelope Protein.
by: Chung-Tao Tang, et al.
Published: (2015-01-01)